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1. Introduction 
The immunological interaction between mother and fetus during pregnancy causes the fetal 
immune system to avoid excessive and destructive immunological reactions. This particular 
physiologic situation coexists with an immature immune system, which makes the infant 
very vulnerable for infections and susceptible to the development of immune system related 
disorders. At birth, the immune system of the infant is particularly characterized by a not 
fully developed non-specific immune system. In addition, a suppressed capacity of antigen-
specific T cells, a deletion of activated T cells, and the presence of high amounts of 
regulatory T cells (Treg) hamper proper immune responsiveness. During the first months of 
life the antigen-specific immune response has to be developed in parallel to the maintenance 
of immune tolerance against compounds commonly found in the environment of mother 
and infant. There is evidence that disturbances of these complex developmental processes 
will have impact on the function of the immune system during lifetime causing 
immunological disorders such as allergy and autoimmunity. 
Human milk contains several immunological active compounds which protect the infant 
from infection. Many of them such as antibodies are individually adapted to the maternal 
environment which is similar to the environment of the infant thus providing individual 
protection to the infant. Apart from this protection activated immediately after birth, human 
milk modulates also the described developmental processes. Although the mechanisms of 
this modulation are not fully understood there is evidence that human milk can transfer 
“immunological memory of the mother” to the infant. This concept of the role of human 
milk underlines the importance of quality of nutrition during first months of life for total 
development of the immune system. Individual human milk analyses will provide insight in 
components that are important modulators. Immunologic active peptides, long chain 
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polyunsaturated fatty acids, several glycolipids and non-digestible oligosaccharides have 
already been identified as such modulators. The interaction of these active components with 
different parts of the immune system is very complex allowing a graduate and balanced 
development of the immune system. 
One problem of studies in animals and humans is the fact that no single biomarker exists 
which describes completely the developmental status of the immune system. Although the 
question which biomarkers are of relevance is still a matter of intensive research there is 
evidence that many “classical” biomarkers are not useful. Many of these “classical” 
biomarkers are only sensitive in case the immune system is out of balance but not during a 
normal development. Consequently, research to identify relevant biomarkers characterizing 
healthy development is strongly required. There are many questions still open. However, 
first results are promising indicating that the quality of nutrition early in life might support 
development of the immune system for lifetime. Acceptance of such a concept might 
provide opportunities for new ways of primary prevention of immune related diseases later 
in life. 
This chapter will summarise the newest and some specific insights of the mechanisms and 
impact of nutrition on the development of the immune system early in life.  
2. Influences prior life 
The nutritional status in early life has an important influence on human immune 
development, for example, a positive association is clearly observed between birth weight 
and antibody response to certain vaccines later in life (McDade, Beck et al. 2001). The 
precise relationship however between nutritional exposures during critical periods of 
development and later immune function warrants further investigation. The early 
postnatal environment is a vital determinant of adult health. An environmental exposure, 
like nutritional modulation of the evolving intestine during early infancy makes an 
impact on the development and function. A concept like this (as illustrated in Figure 1) 
will provide opportunities for primary prevention from immune related diseases later in 
life. 
In order to understand the impact of nutrition on immune development early in life it is of 
key importance to know which steps in immune development are subjective to change and 
depend on specific nutrition. During embryogenesis, stem cells start to differentiate into 
specific progenitor stem cells, creating a pool of more specific and less totipotent stem cells. 
Hematopoietic stem cells (HSC) are the progenitor cells for our whole immune system 
(Figure 2). Identification of the first HSC is still difficult, because these regions don’t contain 
many HSC and unique markers are lacking (Medvinsky, Rybtsov et al. 2011). After these 
few first HSC have colonized the human fetal liver, these cells expand and will relocate 
under influence of adhesion molecules and chemo-attractants to thymus, spleen and bone 
marrow (Mazo, Massberg et al. 2011). The bone marrow will start to produce immune cells 
from the hematopoietic lineage at four to five months of gestation in human pregnancy. 
Upon stimulation with ‘early acting cytokines’ a HSC will proliferate and differentiate into a 
myeloid or a lymphoid precursor cell depending on their surroundings (Grassinger, 
Haylock et al. 2010).  
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Fig. 1. Disturbances of immune developmental processes will have impact on the function of 
the immune system during life causing immunological disorders such as allergic disorders 
and autoimmunity. Although there are many questions still open first results are promising 
indicating that feeding early in life might support the development of the immune system 
for lifetime. 
 
Fig. 2. Hematopoiesis/ immune cell development; From the hematopoetic stem cell the 
different immune cells develop, including; CMP, common myeloid precursor; CLP, common 
lymphoid precursor; DC, dendritic cell; NKT, natural killer T cell; NK, natural killer cell; 
Treg, regulatory T cell; CD8+, cytotoxic T cell; CD4+ Th, T helper cell. 
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2.1 Lymph node formation 
Recent investigation showed that during lymph node development retinyl hydrogenase 
(RALDH) 2 is one of the enzymes essential in initial cross talk between different cell types 
(van de Pavert and Mebius 2010). RALDH-2 converts retinaldehyde to retinoic acid (RA). In 
absence of this enzyme proper lymphoid follicles are not developed. Retinoic acid is the 
active form of vitamin A and is important during embryogenesis, when axial patterning and 
organ formation take place (Campo-Paysaa, Marletaz et al. 2008). RA is involved in nerve 
development and expression of RALDH is found in nerve fibers near the lymph node 
anlagen, where RA can influence stromal cells to produce specific chemokines. Because RA 
is produced and used for different developmental processes, other factors should be present 
to direct lymph node development. One of these factors is CXC chemokine ligand 13 
(CXCL13) produced by lymph node surrounding stromal cells. After a small cluster of pre-
T- and -B cells is formed, more cells are attracted to this specific site for example via CC 
chemokine receptor (CCR) 7 and CC chemokine ligand (CCL) 19 and CCL21. When there 
are enough cells in the cluster, differentiation into lymph nodes occurs. Lymph nodes in the 
intestine are essential for priming of the whole immune system; therefore detailed 
development of the intestinal tract and intestinal immune tissues are described in Box 1. 
Peyers patches (PP) are the local small intestinal lymph nodes and mesenteric lymph nodes 
(MLN) are the collecting lymph nodes for small and large intestine. In essence these lymph 
structures develop very similar but there are some differences. For the development of PP 
the CD11c+ cells are required. In addition there are differences in essential transcription 
factors which are necessary to develop lymph nodes or PP, like interleukin (IL) 7 and RANK 
(Chappaz, Gartner et al. 2010). Using mice deficient for IL7 or Kit or both they showed that 
IL7 is important for lymph node anlagen but not for PP development  whereas both Kit and 
Il7 are important for MLN anlagen (Chappaz, Gartner et al. 2010). But growth factors 
needed for lymph node development still remain poorly understood. The influence of 
vitamin A on the development of lymphoid structures is already a strong indication that 
nutritional components are of key importance at the base of infant’s immune system.  
 
Box 1. 
A human embryo consists two weeks after fertilisation of three layers, called ectoderm, endoderm 
and mesoderm. Ectoderm forms the nervous system and the exterior, endoderm forms among 
others the gastrointestinal tract and the mesoderm forms for example connective tissue and the 
cells of the immune system. In the fourth week of embryogenesis the flat tissue folds lateral and 
folds from head to toe, via which the endoderm is enclosed by the ectoderm and a foregut, midgut 
and a hindgut are being formed, surrounded by mesoderm. At the end of the fourth week the liver 
is also beginning to form. From one of the pouches in the forgut, thymus will be formed, between 
3rd and fourth month during pregnancy. 
The loop of the midgut remains in contact with the yolk sac via the vitalline duct. In the same 
period that the definitive duodenum is formed, the midgut elongates and the hindgut becomes 
enlarged. When these changes in the pre-intestinal tract occur, the midgut migrates to the umbilical 
cord and returns in the embryo before the 4th month. During retraction the gut rotates to its final 
position. Throughout the whole gut enlargement of the surface is initiated via formation of crypts, 
villi and microvilli. The villi and microvilli start to develop after 9 to 10 weeks and at a later stage 
the colon loses it’s villi. After birth the intestine needs approximately one week to organize it’s 
lymph nodes with specific T- and B-cell regions and six months to acquire a tight epithelial barrier. 
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Fig. 3. Immune cell plasticity; Upon antigen encounter and T cell activation, naïve CD4+ T 
cells mature into several subsets. Several factors including cytokines, as described above 
determine the type of immune response, including Th1, Th2, Th17 and regulatory T cells. 
For example Th1 cell differentiation Interleukin (IL)12 and interferon gamma (IFN┛) is 
needed (blue arrow indicates stimulation). These cytokines help up regulate specific 
transcription factors like Tbet and Signal transducer and activator of transcription 4 (Stat4). 
These transcription factors activate certain genes to produce other cytokines like, IL2, LT┙ 
and IFN┛. When these cytokines are produced they help inhibit the differentiation of other 
Th-cells (red arrows indicate inhibition).  
2.2 Immune cell development 
The fetal common lymphoid progenitor cells (CLP) differ from the adult CLPs. The fetal 
CLPs have the ability not only to differentiate into all lymphoid cell types but also into 
macrophages. It is currently not known whether adult CLP are restricted to the division in 
myeloid and lymphoid progenitors or whether it is a gradual loss in lineage commitment 
(Chi, Bell et al. 2009). Via complex processes involving, a positive and negative selection, a 
lineage specific development in the thymus occurs. Only naïve T cells, intermediately 
recognizing the Major Histocompatibility Complex (MHC)-self-peptide and expressing CD4 
or CD8, are allowed to migrate to their target organ (Singer, Adoro et al. 2008). CD4+ T cells 
form a subset of T cells called T helper (Th) cells and these cell types help to activate the B 
cells and CD8+ T cells. Th cells need binding of CD4 and CD28 to become activated Th cells 
and dependent on a specific set of cytokines, CD4+ T cells mature into different kinds of 
effector T cells, memory T cells or regulatory T (Treg) cells [Box 2]. Many factors are 
important for the development of both B and T cells, IL7 is of uttermost importance for both 
lymphocyte lineages (Kang, Der, et al. 2004). Recently it was shown that IL7 helps establish 
B cells, producing IgM,  in the marginal zone of the spleen (Willems, Li, et al. 2011). Directly 
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after birth maternal IL7 increases T cell production in the thymus and supports survival of T 
cells in other lymphoid structures in offspring, underlines the importance of IL7 during 
lymphogenesis (Aspinall, Prentice, et al. 2011). 
The thymus is critically sensitive to malnutrition, with protein nutrition deficiency causing 
atrophy of the thymus (Savino and Dardenne 2010). This suggests that the thymus is a 
putative target for early-life programming effects. Most immune defence mechanisms are 
impaired in malnutrition, even in moderate nutritional deficiency. Protein-energy 
malnutrition is accompanied by deficiencies of micronutrients such as vitamin A, vitamin E, 
vitamin B6, vitamin C, folate, zinc, iron, copper, and selenium. Rapid proliferating T cells 
are especially affected by the lack of essential nutrients. Severe and chronic malnutrition 
may even lead to thymus atrophy affecting the basis of our immune system. The potential of 
adding certain nutrients, like vitamin C, D, or E, at levels above recommended dietary 
allowances (RDA) to the diet may improve immune function, is subject to increasing 
research. 
 
Box 2. 
The B cell lineage develops from HSC at the same sites as T cell development occurs. A 
major difference in lymphocyte development is that B cell development starts earlier, 
already in the pre-aorta gonad mesonephros region, which is also the most potent site for B 
cell development in the fetus (Dorshkind and Montecino-Rodriguez 2007). The HSC that 
migrate into the bone marrow are post natal responsible for B cell production. When B cells 
are activated they start to produce immunoglobulins, soluble and cell surface products to 
neutralize pathogens. Follicular B2 cells respond to microbial infections, they will present 
processed bacterial peptide to their CD4+ T cell partner. Because of this interaction B cells 
will undergo isotype switching and mature into plasma cells secreting antibodies to clear 
the infection. Some of these mature cells become memory B cells in peripheral lymphoid 
organs. Marginal B cells respond to bacterial polysaccharides without T cell stimulation. 
Recently it has been found that regulatory B cells can negatively influence the immune 
response via IL10 and transforming growth factor (TGF)┚ secretion (Vaughan, Roghanian et 
al. 2010). There are T cell independent B cell activators as mentioned above, but there is also 
T cell dependent B cell activation. Th1 type of CD4+ T cells are capable of helping B cells 
redirect to IgG2a in mice and IgG2 in humans. Th2 type of environment can induce 
switching towards IgE and IgG1 in mice and IgE and IgG4 in humans. At first the B cells 
will start with producing IgM and IgD. Upon stimulation they can switch towards an IgA, 
Naïve CD4+ T cells are activated upon encountering an antigen presenting cell expressing MHC 
class II and the co-stimulatory signal CD28. They mature into effector, memory- of Treg dependent 
on which cytokines are produced by their APC. Already in 1986 two subsets were discovered by 
Mosmann and Cofmann (Zhu and Paul 2008) and now many more are well characterized. For Th1 
Tbet and Signal transducer and Activator of transcription (Stat)1 are the initiating transcription 
factors , producing IFN┛, then Stat4 is amplifying the Th1 response. Th2 differentiation is activated 
by IL4, which induces Stat6. Stat6 in turn will activate the transcription factor Gata3. For Th17 
ROR┛t is crucial, it is induced by transforming growth factor (TGF) ┚ with IL6, then Stat3 and IRF4 
are expressed. The transcription factors Foxp3 and Stat5 are needed, but without RA Tregs aren’t 
formed. After the infection is cleared most cells die by apoptosis and some cells become memory 
cells to establish a faster response upon another infection (Zhu and Paul 2008; Zhu, Yamane et al. 
2011). 
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IgE or IgG, depending on their surroundings and seem to be influenced by dietary 
components as discussed later. Neonatal B cells are capable of switching to IgG1 and IgG3 
during the first 2 years of life, but the switch to IgG2 and IgG3 is inadequate during this 
period. To compensate the lack of protection in fetus and newborn, microbe-specific 
maternal IgG antibodies move across the placental barrier to provide some vital protection. 
During the last trimester of pregnancy IgGs are transferred intrauterine to the infant, 
because new-borns memory T cells capable of generating IgG and isotype switching aren’t 
present yet. IgG1 and IgG4 are most effectively transported across the placenta compared to 
IgG3 and IgG2. Transfer of maternal antigen-specific IgG regulates the development of 
allergic airway inflammation early in life in a neonatal Fc region (FcRn)-dependent manner 
(Nakata, Kobayashi et al. 2010). This active transfer of IgGs from mother to child starts at 
week 17 and continues until birth. Moreover, just before birth, IgG levels of prenatal infants 
are even higher than levels present in the mother. The transfer and amount of pathogen 
specific IgGs is dependent on vaccinations and diseases the mother acquired during life. 
Many factors influence the IgG transportation processes which are described in a review by 
(Chucri, Monteiro et al. 2010). IgA IgD, IgM are the only known antibodies acquired after 
birth via breast feeding, covering the lack time during increasing antibody productions of 
infant’s immune system itself. When the infant can produce the different B-cell antibodies, 
the activation, isotype switching and survival of B cells is for example under influence of B –
cell activating factor (BAFF), TGFß1, IL-6, -7 and -10 produced by PP stromal cells (Finke, 
2009). Not much is known about the involvement of Ig free light chains (IgfLC) in humoral 
immune response early in life. However the release of antigen specific IgfLC by B-
cells/plasma cells like for example IgE may have implications for the health status of the 
newborn (Redegeld Nat Med 2003, Schouten JACI 2010). Furthermore compromised 
immune status may result in enhanced production and secretion of IgfLC at the cost of other 
immunoglobulins (van Esch CEA 2010). 
Whereas T and B cell lineage experienced an in dept research into their origin, the origin 
and differentiation of dendritic cells (DC) is in its initial phase. One problem is to define 
specific precursor DC types (Liu and Nussenzweig 2010). Microbial exposure is one of the 
key developing factors for DCs (Plantinga, van Maren et al. 2011). The lamina propria (LP) 
contains mostly fractalkine positive DCs which sample the gut lumen with protrusions 
across the epithelial barrier, and are able to induce a Th17 response. Furthermore, in 
addition to the non-migrating DC population in PP there is a majority of DCs which will 
migrate to specific sites after encountering an antigen. For example the intestinal LP derived 
CD103+ DC subtype will migrate towards the MLN and is known for its capability to elicit a 
regulatory response, in the presence of RA and TGF┚. However if other factors are present a 
Th1 of a Th2 response can be induced. The activated T cell in the MLNs will migrate to the 
site of inflammation for instance in the intestine to initiate a proper immune response 
(Figure 4). Intestinal development is already influenced during pregnancy by the amniotic 
fluid as intestinal epithelial cells of the fetus can react to components in the amniotic fluid 
by different receptor expression (Drozdowski, Clandinin et al. 2010). So during gestation the 
gut can readily react to its micro-environment, but still much is unknown about the 
influence of maternal status on infantile gut development.  
An increasing number of studies have identified interesting links between early nutrition, 
epigenetic processes and disease development later life (Boehm and Moro 2008). As the 
plasticity of growing and developing tissues shapes, the base of the responses to later  
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Fig. 4. Intestinal structure and development is already influenced during pregnancy and 
reacts to its micro-environment. The complex structure includes a variety of cross talk 
between different cells including epithelial cells, dendritic cells  and lymphocytes. The 
lamina propria contains mostly dendritic cells which sample the lumen with protrusions 
across the epithelial barrier; in addition, the CD103+ DC subtype will migrate towards the 
mesenteric lymph nodes (MLN), after which the activated T cell in the MLNs will migrate 
back to the site of inflammation to initiate a proper immune response. 
challenges is established, therefore the exposures during early life may be critical. Folate 
deficiency during pregnancy is associated with increased risk for aberrant reprogramming 
of DNA methylation inducing neural tube defects. Dietary folate intake can restore these 
deficiencies and neural tube defects. Folate is however not the only determinant of DNA 
methylation. Other methyl donor nutrients like betaine, vitamins B2, B6 and B12, and 
methionine, and choline, can also change DNA methylation status and therefore have an 
impact on development early in life (Niculescu and Lupu 2010). 
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3. Postnatal immune development in the gut 
After birth a newborn changes from a sterile environment of the uterus into a world of 
constant challenges. In the first months of life newborns are more dependent on their innate 
immunity and immunoglobulins derived from the mother as described before. IgG is 
already acquired intrauterine but IgM and IgA are ingested via human milk to have an early 
defence against pathogens. Triggering the innate immunity repeatedly to microbial 
challenges after birth helps establishing a normal Th1 response postnatal. But the immune 
response is still less adequate compared to the adult response, possibly due to a general 
lower number of immune cells present. To build up an effective and balanced immune 
system interaction with germs and bacteria is needed (van't Land, Schijf et al. 2011). It is 
important that the immune balance is restored properly because a deregulation early in life 
could trigger an adverse reaction leading to an allergic reaction. The gut is the main 
processing site of food and, here immune tolerance against new food particles is established. 
But an improper chemical barrier and weak mucosal barrier integrity will complicate 
acquiring immune tolerance. There are some factors positively influencing development of 
the gut and immune system during pregnancy and after birth, of which only few of them 
will be discussed in detail below. 
3.1 Influence of vitamins during and after pregnancy 
Vitamin A has been recognized for its importance in lymphoid structure formation during 
embryogenesis. Sources of vitamin A are carrots, liver, sweet potatoes and butter. For 
example vitamin A supplementation before, during and after pregnancy using restricted 
dosages, results in long term positive effects on lung function which could be measured nine 
to thirteen years later.(Checkley, West et al. 2010). Shortly after the recognition of vitamin A 
essence during pregnancy, the teratogenic effect of excess vitamin A was shown. 
Malformations of the central nervous system, the eye and the thymus were found due to 
excessive use of vitamin A (Gutierrez-Mazariegos, Theodosiou et al. 2011). The teratogenic 
danger of vitamin A can also be induced via extra prolonged ingestion of this vitamin 
because it is stored in fat cells in the liver. It was already mentioned that RA could increase 
the progression from HSC into myeloid cell lineage. When RA is lacking from the diet CD4+ 
and CD8+ T cells and IgA+ B cells aren’t found in the LP of the intestine, whereas CD4+ T 
cells were still present in lung tissue (Iwata 2009). Recently it was shown that stromal cells 
and DCs in the MLN induce high levels of RALDH expression postnatally, dependent on 
vitamin A and not on toll like receptor (TLR) signalling (Molenaar, Knippenberg et al. 2011). 
They compared MLN with other lymph nodes at different postnatal weeks and found an 
increased expression of RALDH only in the MLN residing DC, almost exclusively in 
CD103+ MHC-II+ CD11c+ DC cells. Vitamin A deficiency reduces this RALDH expression 
significantly. In addition, RA skews DC towards tolerance induction via instruction of 
Foxp3 Treg in the mother during pregnancy and in the infant just after birth (Coombes, 
Siddiqui et al. 2007; Duriancik, Lackey et al. 2010). Also vitamin A is necessary for the 
intestinal homing properties of activated T cells, Treg and certain B cells. In vitro it was 
shown that naïve CD4+ cells induce gut homing receptors when they are activated by CD3 
and CD28 together with RA, this combination simultaneously down regulates skin homing 
receptors (Iwata 2009). In vitro DC from the gut associated lymphoid tissue could also 
induce activated IgA secreting B cells more effectively when RA was present in the medium, 
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however the intracellular mechanism needs to be determined (Mora and von Andrian 2009). 
Not only RA is important for IgA secreting B cells, IL5 is essential for IgA production and 
TGF┚ increases IgA secretion in vitro. There is also a positive feedback loop, IL6 stimulates 
IgA induction by DC and IL6 is induced by RA. Synergistic effect on IgA induction could be 
obtained by the aforementioned cytokines and therefore immune protection of the infant 
could be achieved (Mora and von Andrian 2009; Duriancik, Lackey et al. 2010). This 
indicates that also during early infancy the level of vitamin A is of importance for proper 
immune functioning, which may have profound consequences later in life.  
An additional vitamin of interest for immune development is vitamin D. Worldwide there is 
no consensus on the healthy levels of vitamin D intake before and during pregnancy. 
Already during the first trimester of pregnancy vitamin D could be of importance for the 
development of the fetus. The 25-hydroxy vitamin D-1┙-hydrolase CYP27B1), which 
converts vitamin D into its more active metabolite 1,25 (OH)2D, can be detected in the 
placenta. There is some speculation about vitamin D deficiency and reduced fertility, this 
fertility problem may be caused by a reduced down regulation of the Th1 response by high 
levels of vitamin D as well as circumstantial evidence pointing at a relation between 
gestational diabetes and preeclampsia in correlation to circulating vitamin D levels (Dror 
and Allen 2010). In addition, vitamin D is important for the clearance of certain infections 
(Hoyer-Hansen, Nordbrandt et al. 2010).  
Vitamin D is linked to monocyte activation via activation of TLR2 and TLR1(Lagishetty, Liu 
et al. 2011). Recently it was shown that IL4 and IFN┛ are involved in the regulation of 
vitamin D expression (Edfeldt, Liu et al. 2010). IL4 promotes expression of CYP24A1, which 
down regulates active vitamin D, and IFN┛ positively influences the expression of CYP24B1 
in monocytes. Then it is suggested that vitamin D could skew the balance between Th1 and 
Th2 towards a Th2 phenotype directly or indirectly via monocyte activation, which however 
may be much more complex in vivo (Adams and Hewison 2008). Low vitamin D levels 
during pregnancy are suggested to be related in the development of food allergy (Nwaru, 
Ahonen et al. 2010). It was recently shown that active vitamin D can suppress DC 
maturation and inhibit T cell proliferation. Mature DC have high levels of vitamin D 
converting enzymes, suggesting that upon Vitamin D addition, mature DC can inhibit the 
development of immature DC. Suppression of DC maturation could then via vitamin D 
promote tolerance. Research with vitamin D receptor (VDR) and CYP27B1 knockout mice 
showed abnormal lymph node development due to the presence of more mature DC and 
increased DC trafficking (Hewison 2011). 
There is still debate about the healthy amount of vitamin D intake during pregnancy (West, 
Videky et al. 2010). Indeed some studies show that vitamin D intake is associated with 
diminished wheeze, asthma and eczema in offspring (West, Videky et al. 2010). For vitamin 
D it is clear that lymphocytes are influenced, but to what extent this affects function later in 
life remains to be established. Increasing evidence from observational studies in infants at 
older ages, indicate that vitamin D insufficiency and deficiency might increase the risk of 
chronic diseases such as type 1 diabetes and multiple sclerosis. However, clear randomized 
trials on this association need to be conducted to confirm these findings. In the last decades, 
observations accumulate that vitamin D deficiency leads to more often and more serious 
respiratory infections than in individuals with sufficient vitamin D plasma levels. This 
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illustrates the importance of the nutritional status early in life, to set the proper immune 
balance (Karatekin, Kaya et al. 2009).  
3.2 Human milk 
It is well established that breastfeeding reduces the incidence of gastrointestinal and non-
enteric infections in infants, due to its antimicrobial activity against several viruses, bacteria, 
and protozoa (Chirico, Marzollo et al. 2008). In addition, it was shown that infants, breastfed 
for more than 4 months experienced significant reduced incidences of respiratory tract 
infection requiring hospitalization, as compared to infants who were not breastfed 
(Bachrach, Schwarz et al. 2003). Moreover, other studies showed that breastfeeding provides 
protection against urinary tract infections and otitis media and it reduces the development 
of inflammatory conditions like allergy (Fiocchi, Martelli et al. 2003), Crohn’s disease and 
ulcerative colitis (Hanson 2007). This, moreover, emphasizes the diversity of activity and 
active components present in human breast milk. Although it is clear that allergy 
development is influenced by breast milk as well as atopy related disorders, still some 
controversy exists regarding the beneficial length of breastfeeding (van Odijk, Kull et al. 
2003). These protective effects of human breast milk seem to persist at least during the first 
decade of life.  
Fortunately prenatally the infant is supplied with maternal immunoglobulins, for the first 
protection against infections. It takes at least one year before an infant can produce about 
60% of its IgG levels on its own. After birth the child can be supplied with essential IgG, IgM 
and IgA via human milk. For example, IgA is necessary as the first line of defence against 
microorganisms. This immunoglobulin also controls commensal (also called beneficial) 
bacteria all without activation of an inflammatory response. Because infants do not have an 
optimized Treg response and no memory cells, B cells cannot be directed to produce the 
right amount of Ig antibodies quickly as a first defence. IgM helps to eliminate the pathogen 
before IgGs are produced. As earlier mentioned IgM is normally produced by naive B cells 
before isotype switching occurs. The B cell response needs time after birth to be fully 
functional, so acquiring this component via human milk strengthens the first line of defence. 
Not only antibodies are factors present in human milk, other immune modulating 
components are present, including cytokines, non digestible oligosaccharides and poly 
unsaturated fatty acids (PUFA), which are discussed in more detail below.  
3.3 Cytokines 
TGF┚ and IL10 are held responsible for the induction of oral tolerance in the intestine (du 
Pre and Samsom 2010). They educate the immune system locally not to respond to harmless 
antigens. In human milk TGF┚2 is the predominant isoform of the three existing 
mammalian isoforms. Addition of TGF┚2 to infant formula, can skew the Th2 allergic 
effector response towards Th1 in rat pups exposed to ┚-lactoglobulin, a cow’s milk allergy 
protein (Penttila 2009). Not TGF┚2 but TGF┚1 is the major player to establish immune 
tolerance to food in the adult system. To guarantee the uptake of TGF┚, TGF┚ receptors are 
abundantly expressed in the neonatal intestine, even the soluble TGF┚2 receptor is present 
in breast milk. But in addition it was found that TGF┚ is not essential for tolerance induction 
when milk born-IgG antigen immune complexes are present (Verhasselt, Milcent et al. 2008). 
Moreover it is known that high levels of TGF┚ together with RA skew the immune system 
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towards a regulatory suppressive function, a low dose of TGF┚ combined with IL6 or IL21 
or IL23 will result in inflammatory Th17 activation instead of Treg upregulation (Konkel 
and Chen 2011). Recently Hering et al (2009) showed that in vitro TGF┚  probably helps 
forming the intestinal epithelial barrier via exerting its effect on the reinforcement between 
the epithelial cells (van't Land, Meijer et al. 2002; Hering and Schulzke 2009). The production 
of IgA is also positively influenced by TGF┚ (Cazac and Roes 2000; Borsutzky, Cazac et al. 
2004). This indicates that the immune modulating components have their function alone, but 
this needs to be further investigated in combination. 
3.4 Nondigestible oligosaccharides 
There are different types of soluble dietary fibres e.g. (hemi)cellulose, lignin, ┚-glucans, 
pectins, gums, inulin and oligofructose. In addition different non-digestible oligosaccharides 
with specific properties are obtained or manufactured from natural sources (Calder, Krauss-
Etschmann et al. 2006). Human milk contains approximately 7-12 g/L oligosaccharides 
(Hoppu, Kalliomaki et al. 2001). At least 130 different oligosaccharides have been isolated 
from human milk and the two main categories are neutral and acidic oligosaccharides (Lara-
Villoslada, Olivares et al. 2007; Greer, Sicherer et al. 2008). These oligosaccharides are non-
digestible carbohydrates that have many different properties and are believed to act on the 
microbiota in the gut (Host, Koletzko et al. 1999; Halken, Hansen et al. 2000; Hill, Murch et 
al. 2007; Niggemann and Beyer 2007). Due to physicochemical properties of non-digestible 
carbohydrates the absorption of minerals and fecal consistency improves. Some of these 
have specific properties and can be used as prebiotics as a dietary supplement. Prebiotics are 
defined as “a selectively fermented ingredient that allows specific changes, both in the 
composition and/or activity in the gastrointestinal microflora that confers benefits upon 
host wellbeing and health” (Host and Halken 2004). Prebiotics enhance defense mechanisms 
of the host by stimulation of growth of Bifidobacteria and Lactobacilli. As the intestinal 
microbiota plays a critical role in the establishment and maintenance of healthy immune 
responses, the delayed colonisation of the infant gut with commensal bacteria are suggested 
to be a risk factor for the development of immune mediated chronic disorders such as 
allergic and autoimmune diseases. Short-chain fatty acids, released by these bacteria upon 
fermentation of prebiotics, are essential nutrients for intestinal epithelial cells and support 
gut function (Gibson and Roberfroid 1995; Nakhla, Fu et al. 1999; Boehm and Stahl 2007). In 
vivo and in vitro studies have shown beneficial effects of prebiotics on the innate as well as 
the adaptive immune system (Boehm, Fanaro et al. 2003). Short-chain galacto-
oligosaccharides (scGOS), long-chain fructo-oligosaccharides (lcFOS) and pectin-derived 
acidic oligosaccharides (pAOS) are some examples of non-digestible oligosaccharides that 
mimic the functionality and molecular size distribution of human milk oligosaccharides.  
The effects of scGOS and lcFOS (9:1)(Immunofortis®) have been studied in a murine 
vaccination model (Vos, Haarman et al. 2006), in an allergic asthma model (Vos, van Esch et 
al. 2007) and a cow’s milk allergy model (Schouten, van Esch et al. 2009). The response to 
vaccination of mice fed the scGOS/lcFOS diet was significant enhanced, as well as the fecal 
Bifidobacteria and Lactobacilli proportions. pAOS enhanced the murine vaccination 
response and the combination (scGOS/lcFOS/pAOS) was even more effective (Vos, 
Haarman et al. 2007). To stimulate the entire microbiota a great variation in the 
oligosaccharide structures will exert this effect, as human milk oligosaccharides comprise of 
many different oligosaccharides. The pAOS are not only another group of oligosaccharides, 
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they act very specifically to their acidity. Based on this they are able to interact with surfaces 
and might prevent the adhesion of pathogens on the intestinal epithelium. In infants pAOS 
showed  no difference in stool characteristics, pH, growth, crying, vomiting and 
regurgitation patterns as compared to control formula. In addition pAOS alone did not 
affect intestinal microecology (Fanaro, Jelinek et al. 2005). Furthermore, systemic Th1 
dependent immune responses were enhanced using the prebiotics without inducing 
autoimmunity, as Th1 is low in newborn infants. In addition, in a murine model for cow’s 
milk allergy dietary intervention with scGOS/lcFOS showed significant decrease of the 
allergic response and increased specific IgG2a levels (Meyer 2004; Schouten, van Esch et al. 
2009).  
Recently it was found in mice that dietary intervention with scGOS/lcFOS/pAOS reduces 
the development of an acute allergic response upon antigen challenge, although specific 
immunoglobulins levels remain high. Ex vivo depletion of CD25+ Treg abrogated the 
diminished acute allergic response, combined with adoptive transfer studies, imply crucial 
involvement of antigen specific CD25+ Treg cells in the suppression of the allergic effector 
response (Schouten, van Esch et al. 2010; van't Land, Schijf et al. 2010; Schouten, van Esch et 
al. 2011). Furthermore, clinical trials have been performed with the scGOS/lcFOS mixture in 
children at high risk for allergies. A reduction in the incidence of atopic dermatitis (AD) 
(Moro, Arslanoglu et al. 2006) and the incidence of allergic manifestations during the first 6 
months of life (Arslanoglu, Moro et al. 2007) was observed, furthermore this reduction 
lasted at least until 2 years of age (Arslanoglu, Moro et al. 2008).  
Recently, it was also shown, in a multicenter trial, that the scGOS/lcFOS/pAOS mixture 
could reduce the incidence of AD in healthy not at risk children (Gruber, van Stuijvenberg et 
al.). In another clinical study, using the scGOS/lcFOS mixture, fecal secretory IgA was 
increased in healthy infants (Bakker-Zierikzee, Tol et al. 2006). Also in healthy infants there 
is cumulative evidence that prebiotic mixtures might beneficially affect the host in both Th1 
as well as Th2 prone settings as it might prevent food allergy (Th2) and enhances the 
vaccination response (Th1). Although it is believed that prebiotics exert their effect via 
stimulation of growth of selective bacterial species that beneficially improve host health, 
there is debate about this mechanism and there are potentially microbiota-independent 
mechanisms as well (Boehm, Fanaro et al. 2003; Vos, M'Rabet et al. 2007). As it was shown 
that epithelial cells can transport scGOS, lcFOS and pAOS across from apical to the 
basolateral side (Eiwegger, Stahl et al. 2010), this illustrates that besides a prebiotic immune 
modulating effect the oligosaccharides also come in direct contact with immune cells 
themselves, making it possible to act directly on the immune cells.  
3.5 Poly unsaturated fatty acids 
Omega-3 and omega-6 poly unsaturated fatty acids (PUFA) are essential for humans and 
have to be provided via the diet especially found in seafood. PUFA are incorporated into the 
cellular membrane and are eicosanoid precursors hereby affecting the immune response. In 
this regard in particular n-3 long chain (LC)-PUFA eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) are regarded to be anti-inflammatory while n-6 LCPUFA, like 
linoleic and arachidonic acid, are able to boost inflammatory responses. Arachidonic acid, 
for example can be converted into 2 series prostaglandins, these are able to increase IL4 and 
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decrease IFN┛, and 4 series of leukotrines, which are able to induce endothelial permeability 
and production of inflammatory cytokines (Moreno 2009).  
In westernized countries the n-3 fatty acid ingestion is no longer favoured over n-6 PUFA 
which may have implications for immune homeostasis. It has been stated that the original 
diet of the human race had an n-6 : n-3 ratio of approximately 1:1 and that this has changed 
over the past decades to a ratio of at least 15:1 (Simopoulos 2008). This shift is suggested to 
be explanatory for the increased incidence of cardiovascular diseases, chronic inflammatory 
diseases, obesity and also allergic diseases. Therefore pre-clinical as well as clinical trials are 
performed in order to investigate this hypothesis.  It has been reviewed that n-3 LCPUFA 
intake reduces the incidence of allergic disorders, e.g. AD, less sensitization to egg in the 
clinical trials (Blumer, Pfefferle et al. 2007). Two studies by Dunstan et al. show reduced 
sensitization to egg and less AD in offspring when pregnant woman were supplemented 
with fish oil, which contains EPA and DHA (Dunstan, Mori et al. 2003; Dunstan, Roper et al. 
2004). They found a positive influence of n-3 LCPUFA on TGF┚ mRNA levels in maternal 
peripheral blood and cord blood. This could imply a regulatory function of n-3 LCPUFA, 
but mRNA still needs to be processed towards an active component. Recently, it was shown 
that maternal n-3 LCPUFA intake decreased the risk of food allergy and IgE-associated 
eczema in children at risk for allergy (Furuhjelm, Warstedt et al. 2009). This shift in the 
decrease of allergy can be explained since n-3 LCPUFA is incorporated in the membrane of 
immune cells at the cost of n-6 LCPUFA as arachidonic acid, skewing towards a less 
inflammatory cytokine surrounding. In contrast, in a clinical study by Almqvist et al., 
(Almqvist, Garden et al. 2007) it is shown that supplementation of n-3 PUFA, starting at a 
maximum of six months of age, did not prevent children with a family history of asthma 
from developing atopy, eczema nor asthma at the age of 5 years. Hence discrepancy on 
effects of n-3 PUFA in prevention of allergic disease exists. There are also discrepancies 
between studies in the preparation of fish oil, influencing EPA and DHA content (Prescott 
and Calder 2004). Of concern is the dosage in human studies, this is often much lower than 
used in animal studies, which makes it difficult to extrapolate the outcome and could 
explain differences observed. However interventions using dietary factors like LCPUFAs are 
under-explored and that there is a need for additional research. One of the strategies that are 
proposed is the use of selected LCPUFA in the formula feeding of young children at high 
risk for allergies (Vanderhoof 2008). Another strategy could be to supplement a novel 
LCPUFA during pregnancy; LCPUFA maybe has its largest positive effect on an infant 
health status when primary immune responses are still developing. In addition novel 
synthetic LCPUFA may reveal to be potent in the reduction of the allergic burden (Prescott 
and Calder 2004). 
4. Consequences later in life conclusion 
During the different phases of life, several nutritional factors influence our immune system 
and immune responsiveness in collaboration with endogenous immune modulating 
mediators like humoral factors, lipids and oligosaccharides. A vast amount of literature is 
available on the role that nutrients and human milk (as reviewed in this article), have on the 
development of the immune system; a lot less is known about the exact requirements in the 
phases thereafter, in toddlers, during adolescence, and in the later stages of life. Moreover, 
as no single biomarker exists able to determine a proper functioning immune system, it is 
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almost impossible to describe completely the developmental status of the immune system 
and the important influences of nutrition. Although it is clear that each phase in life puts 
specific requirements on nutrition, no clear statement can be made based on literature as to 
what the exact dietary requirements are in order to fully support the immune system during 
these stages in life. But food as a beneficial dietary component is currently under very active 
scientific investigation, so more information about nutrition will be available soon. 
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